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Abstract
Background:  Accurate analyses of comprehensive genome-wide SNP genotyping and gene
expression data sets is challenging for many researchers. In fact, obtaining an integrated view of
both large scale SNP genotyping and gene expression is currently complicated since only a limited
number of appropriate software tools are available.
Results: We present SNPExpress, a software tool to accurately analyze Affymetrix and Illumina
SNP genotype calls, copy numbers, polymorphic copy number variations (CNVs) and Affymetrix
gene expression in a combinatorial and efficient way. In addition, SNPExpress allows concurrent
interpretation of these items with Hidden-Markov Model (HMM) inferred Loss-of-Heterozygosity
(LOH)- and copy number regions.
Conclusion: The combined analyses with the easily accessible software tool SNPExpress will not
only facilitate the recognition of recurrent genetic lesions, but also the identification of critical
pathogenic genes.
Background
High-density genome-wide views of biological samples,
using high-throughput DNA mapping and mRNA gene
expression microarrays facilitate the identification of
recurrent molecular lesions. Both types of microarrays,
which are being produced by different manufacturers, e.g.,
Nimblegen, Agilent, Sequenom, Applied Biosystems, Illu-
mina and Affymetrix, typically contain large numbers of
small oligonucleotides that interrogate the genome. Cur-
rently available DNA arrays contain over 500.000 probe
sets, while the gene expression arrays target over 20.000
genes. Efficient analysis of these large datasets remains a
challenge for many researchers.
The Affymetrix and Illumina DNA mapping platforms
have been designed to specifically target sequences con-
taining single nucleotide polymorphisms (SNPs). SNPs
are currently estimated to be present at a frequency of 1
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out of 300 nucleotides [1]. By including different probe
sets to detect the possible SNP variants, genome-wide gen-
otyping is feasible. In fact, these types of arrays have been
developed for genome-wide association studies; however,
these platforms can easily be applied to determine copy
numbers of these chromosomal markers, similar to array
comparative genomic hybridization (CGH). Because of
the high number of SNPs, sample DNA can be examined
with an inter-marker distance of 6 to 12 kb, and (micro)
deletions and/or amplifications are detectable. By com-
paring disease samples to normal germ line DNA, a
detailed overview of acquired gains and losses of the
genome is obtained. In fact, although our knowledge is
still developing, it has recently become apparent that that
copy number variation (CNV) accounts for a substantial
amount of genetic variation in the human genome [2].
The high-resolution scanning technologies enable the
analyses of CNV and associated phenotypes [2].
The power of DNA mapping has been shown extensively
in cancer research. Chromosomal gains and losses as well
as regions of loss-of-heterozygosity (LOH) have been
shown in, for instance, leukemia [3,4], lung cancer [5-7]
and colon cancer [8]. Recognition of recurrent lesions will
ultimately result in the identification of pathogenic genes.
For instance, SNP array analysis of a set of cancer cell lines
has lead to the identification of the microphthalmia-asso-
ciated transcription factor MITF as a melanoma oncogene
[9].
On the Illumina platform genotypes are determined using
hybridization of genomic DNA to BeadChips followed by
an enzymatic discrimination step. On the Affymetrix plat-
form, genotype calls and copy numbers are determined by
a probe set consisting of mismatch and perfect match
probes. In analogy with the expression probe set, the gen-
otype and copy number of an individual SNP is depend-
ent on the balance of genotype calls in the associated
probe set. Several methods for genotype calling [10-13]
and assessment of copy number [14,15] have been devel-
oped. Advanced analysis methods of DNA mapping array
data have focused on the identification of regions of LOH,
or gains and losses [16-19].
A particular SNP genotype or a numerical change in chro-
mosome copy number can have profound effects on gene
expression. A possible relation to tumor development was
shown in breast cancer, where a 17q23 amplification was
related to increased expression of genes at that locus [20]
and in acute myeloid leukemia (AML), where amplifica-
tion of 8p24 was associated with increased expression of
genes such as MYC [21]. In fact, SNPs as well as CNVs
have recently been shown to have consistent effects, often
in cis, on gene expression [22,23]. The integrated analysis
of gene expression and SNP array data is a prerequisite to
recognize these effects. To our knowledge, only one soft-
ware package is able to visualize chromosome copy
number and gene expression levels [17]. Here, we present
a package, SNPExpress, which allows concurrent interpre-
tation of genotype, HMM inferred LOH regions, copy
number, CNVs, HMM inferred copy number and gene
expression data. Due to the simple format of the input
data, our package is not restricted to specific methods to
determine genotype, copy numbers or expression level.
Little knowledge of software is necessary to use SNPEx-
press, making the tool accessible for a wide audience.
Implementation
SNPExpress, written in JAVA (version 1.5), uses tab-delim-
ited files as input and is currently available for use with
Affymetrix DNA mapping arrays (10 K 2.0, 100 K set and
500 K set), Illumina HumanHap550 Genotyping Bead-
Chip and Affymetrix GeneChips (HG-U95Av2, HG-
U133A and B, HG-U133 plus 2.0). A file containing a
matrix with each column representing the genotypes of
one array and rows starting with Illumina or Affymetrix
SNP IDs is mandatory. The genotype should be formatted
as homozygous 'AA' or 'BB', heterozygous 'AB', or, 'noCall'
(Affymetrix)/'NC' (Illumina). Similar matrix files contain-
ing copy numbers or gene expression values are optional.
Copy numbers should be centered around 2, where 2 rep-
resents the normal copy number of the autosomes and 1
for the male X chromosome. The maximum displayed
copy number is 4, in case the copy number is above 4 this
is indicated by the greyblue background. Copy number-,
genotype- and gene expression files required for SNPEx-
press can be generated through tools such as Affymetrix
BRLMM [13], GCOS/CNAT 4.0 [24], or dChipSNP [17]
with additional formatting in Microsoft Excel. In case of
Illumina data, SNP Express includes the non-synonymous
SNPs and the MHC region, however, mitochondrial SNPs
and Y-chromosome SNPs are not visualized. All files can
be optionally uploaded as tab- or comma-delimited .txt
files or binary files. These binary files can be created from
.txt files by the menu item 'convert data source'.
SNPExpress maps both the SNP IDs (Illumina and
Affymetrix) and the expression probe set IDs (Affymetrix)
to the genome through internal alignment tables, using
annotation provided by the manufacturer [25,26] and
[27]. Annotation was generated using NCBI build 36.1.
Regions showing LOH are calculated through a hidden
Markov Model, which has been described previously [18].
The probability values for heterogeneous calls required
for the HMM have been generated through sets of geno-
types of normal samples. For the 100 K and 500 K array,
90 samples and 270 samples, respectively, of different eth-
nical background from the HapMap project are available
through the NCBI GEO website (and provided by theBMC Genomics 2008, 9:41 http://www.biomedcentral.com/1471-2164/9/41
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manufacturer) [28,29]. For the 10 K array normal
matched blood samples available through the GEO public
repository have been processed [30]. Since reference nor-
mal Illumina genotype datasets are currently not publicly
available, LOH regions using this platform are not sup-
ported in this version of SNPExpress.
SNPExpress includes the option to visualize the results of
a novel analytical method that infers the copy number of
each SNP based on a HMM model, which is implemented
in dChipSNP [17,31]. Also, all CNVs [2], currently catal-
oged in the Database of Genome Variants [32], can be vis-
ualized.
Example expression, copy number, genotype and HMM
copy number example files of two AML patients can be
downloaded from [33].
Results
Genotypes and copy numbers are displayed as sequential
blocks of which color indicates genotype, horizontal coor-
dinate indicates position on the chromosome and vertical
coordinate indicates copy number (Figure 1). The colored
genotype blocks are drawn sequential in chromosome-
wide view and proportional to chromosomal location
when zoomed into a region of interest. Gene expression
levels are visualized as vertical bar at the chromosomal
position of the gene-specific probe set. The height of the
bar is proportional to the gene expression value. The
default value is 500 and expression higher than 500 is
capped at 500, however, these values are user-definable.
In the event that multiple probe sets span the same region
in the chromosome-wide view the vertical gene expression
bars are red and proportional to the highest expression
value. Zooming into the location of interest discloses the
individual probe sets. Links of SNP IDs to public data-
bases are available by holding the ctrl-key and clicking on
a SNP ID.
Distinct background colors are used to accentuate
genomic changes. Individual copy numbers are indicated
as gain (pink background) or loss (green background)
when their value exceeds a user-defined value. The default
deviation threshold is 0.5. LOH is highlighted at diploid
level by a bold magenta line (Figure 1). All colors can be
adapted to the users' preferences.
From the menu, the user is able to choose to visualize
either one chromosome of multiple samples or the com-
plete genome of one sample. Detailed information, con-
taining information such as SNP ID, associated gene
symbol, probe set ID, cytoband and expression value, is
shown on a mouse-over display. Furthermore, a gene of
interest is directly visualized through a search function,
and its associated SNPs are indicated with an orange back-
ground color. The options to display known CNVs (pur-
ple background) or the HMM copy number results (thin
magenta line) are included (Figure 1C). Finally, relevant
data of a particular minimal deleted of amplified region
can be exported (i.e. Sample, Probe_set_id, Chromosome,
Location (bp), Cytoband, Associated gene, Genotype,
Copy number and Inferred LOH of the selected region)
and high-resolution images of the visualization can be
saved in the Portable Network Graphic (PNG) format.
To illustrate the power of SNPExpress, DNA mapping
array profiles of tumor samples of a series of 48 patients
with AML were generated using Affymetrix 250 K NspI
DNA mapping arrays. Ficoll separation of the mononu-
clear cells from AML typically yields >80% pure popula-
tion of leukemic blast cells. High molecular weight DNA
was isolated from these malignant cells and the Affymetrix
mapping arrays were used according to the protocol of the
manufacturer. Genotypes were calculated using BRLMM
and copy numbers were assessed using dChipSNP. Biotin-
labeled cRNA of the same AML samples was hybridized
on Affymetrix HG-U133 plus 2.0 GeneChips, as described
elsewhere [34]. The resulting dataset was imported in
SNPExpress for analyses. Large chromosomal regions
showing loss or gains of genetic material are known to be
apparent in leukemic blasts of AML patients. Well-known
examples of chromosomal lesions in AML are mono-
somies of chromosome 5 and 7, which have been associ-
ated with a poor prognosis [35]. Using SNPExpress,
monosomies of chromosome 7 were evidently demon-
strated in AML samples, previously shown by cytogenetics
to have lesions involving chromosome 7 (Figure 1).
SNPExpress also correctly predicted the presence of LOH
as a result of the absence of one chromosome 7. In fact, 17
out of 21 numerical cytogenetic aberrations, i.e., whole
chromosomes and interstitial deletions, in 48 AML sam-
ples analyzed, were recognized by using SNPExpress. Four
numerical abnormalities abnormalities, present in less
than 30% of the AML cells, were missed. Chromosomal
gains, losses as well as uniparental disomy (UPD) may
also have other important consequences, such as affecting
expression of (imprinted) genes. Combinatorial visualiza-
tion of genotype, copy number and gene expression is a
prerequisite to recognize these aberrations. For example,
the majority of genes show located on chromosome 7
show an overall decrease in expression in AML samples
with a monosomy 7 (Figure 1).
Large regions of homozygosity are present in approxi-
mately 20% of primary AML cases as a result of segmental
UPD [3,36]. These regions of UPD seemed to be non-ran-
dom and may be used to unmask pre-existing recessive
mutations in leukemia genes, such as CEBPA, WT1, FLT3
and  RUNX1 [3,37]. SNPExpress adequately identified
regions of UPD involving e.g. chromosome 11p (FigureBMC Genomics 2008, 9:41 http://www.biomedcentral.com/1471-2164/9/41
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1D), in two patients with a normal karyotype. UPD
involving chromosome 11 is associated with homozygous
mutations in WT1 [37]. Interestingly, in 13 out of 48 AML
patients (27%) large regions of segmental UPD continu-
ing to the telomere were recognized using SNPExpress.
These examples demonstrate the power of SNPExpress. To
our knowledge, no tool is currently available that allows
concurrent interpretation of genotype, HMM inferred
LOH regions, copy number, CNVs, HMM inferred copy
SNPExpress Screenshot Figure 1
SNPExpress Screenshot. A. DNA mapping array data from the Affymetrix 250 K NspI DNA mapping array was used to 
sequentially align the genotypes and copy numbers of chromosome 7 of four AML samples. The copy numbers (n = 0, 1, 2, 3, 
4) are shown for each individual patient by horizontal lines. Copy number n = 2 is depicted by a green line (A). The SNP geno-
types are sequentially aligned along the chromosome (AA: red; BB: yellow; AB: blue, noCall: white). LOH is indicated by a thick 
magenta horizontal bar (B), gains (default n > 2.5) by a pink (Figure 1C) and losses (default n < 1.5) by a turquoise background 
(C). Gene expression levels are visualized as vertical white bar at the chromosomal position of the gene-specific probe set. In 
the event that multiple probe sets span the same region in the chromosome-wide view the vertical gene expression bars are 
red and proportional to the highest expression value. The two upper samples clearly display a decreased copy number as was 
previously shown by cytogenetics, i.e., a complete monosomy (sample 1) or a deletion of the q-arm of chromosome 7 (sample 
2). The overall expression of the majority of genes in the displayed region is decreased in the samples with chromosome 7 
abnormalities. The chromosome selector (D; where 23 is the X chromosome), the mouse-over function showing info of each 
SNP or probe set (E), full chromosome view (F), zoom function (G) gene search function (H), the links to external databases 
(I), display CNVs (J) and export selected data (K) options are indicated. B. Full chromosome view of samples from 1A. C. CNV 
(purple background) and copy number of each SNP based on a HMM model (HMM copy number, magenta line) of the two 
AML patients from examples [33]. In the event that multiple CNVs span the same region in the chromosome-wide view the 
background is violet, whereas single CNV are indicated with a rosy brown background. D. UPD of chromosome 11 demon-
strated using SNPExpress. Example of large scale UPD on chromosome 11 in the upper two AML patients with a normal kary-
otype in comparison to two other AML samples. The overall copy number is two and large regions of LOH are indicated by 
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number and gene expression data. Moreover, no special-
ized knowledge is necessary to work with SNPExpress.
Discussion
Since genome-wide DNA mapping array and mRNA
expression studies become more cost effective, the
number of samples profiled on these platforms will
increase. Specialized user-friendly tools for efficient visu-
alization, such as SNPExpress, will therefore be indispen-
sable. In fact, the initial version of SNPExpress has already
been successfully applied in showing segmental uniparen-
tal disomy as a recurrent mechanism for homozygous
CEBPA mutations in acute myeloid leukemia [38].
Other tools for visualizing and processing SNP array data,
such as SNPScan [39], SIGMA [40], Array Fusion [41],
Partek Genomics Suite [42] and GenePattern [43] have
been developed. Most of these tools incorporate visualiza-
tion options for displaying LOH (GenePattern, Partek
Genomics Suite, SNPScan) and copy number (all but
ArrayFusion), whereas SNPScan and ArrayFusion have
output functionality that facilitates linking SNP data to
the UCSC genome browser [39,41]. Some are linked to a
private database, which restricts pre-processing of the
array data, but gives the advantage of data storage [40].
GenePattern and the Partek Genomics Suite provide nor-
malization and data smoothing functionality. These two
packages and SNPScan have also incorporated options for
combined analysis of paired samples, i.e., tumor and nor-
mal. Like SNPExpress, SNPscan, GenePattern, and the
Partek Genomics Suite can detect regions of LOH, ampli-
fication and deletion. None of these tools describe the
ability to process Illumina BeadArray files. Where SNPEx-
press may lack the opportunity to directly process raw
data files (such as Affymetrix CEL-files), it adds integrated
visualization of expression (Affymetrix) and DNA copy
number and genotype (Affymetrix and Illumina) data.
Moreover, we believe that this is provided in a user-
friendly way that does not require specialist computer
knowledge.
SNPExpress has some limitations. A full-length chromo-
some view depicting gains, losses and the regions showing
LOH is feasible using SNPExpress. However, the large
datasets generated by the 500 K mapping array platform
makes it impossible to visualize the sequentially aligned
SNPs of the full-length chromosomes on one screen.
Selecting the most informative SNPs, i.e., representative
for particular haplotypes, may solve this issue. Such algo-
rithms are currently in development. Furthermore, the
current implementation of the HMM could also be
improved by implementing a HMM that takes into
account the effects of linkage disequilibrium, i.e., LD-
HMM [18]. The number of samples to be visualized con-
currently is limited by the memory available to the appli-
cation.
Conclusion
The power of SNPExpress, as with previously developed
tools [44], is its high accessibility and powerful visualiza-
tion, which facilitates the identification of biologically
and clinically relevant entities. We have shown that recur-
rent biologically relevant entities, such as chromosomal
gains or losses and LOH in AML, are accurately identified
with SNPExpress. Hence, SNPExpress will be beneficial to
genome-wide studies by providing an integrated view of
data from DNA mapping and mRNA expression arrays in





(Including downloadable genotype-, copy number-,
expression- and HMM copy number example files of two
AML patients genotyped with Affymetrix 250 K NspI DNA
mapping array and gene expression profiled with Affyme-
trix U133Plus2.0 GeneChips)
Operating system: Platform independent
Programming language: JAVA
Other requirements: JAVA 1.5 or higher.
License: The tool is available free of charge. Source code is
available upon request.
Any restrictions to use by non-academics: None
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